Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Drugs Made In America Acquisition Ii Corp. (DMII) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Drugs Made In America Acquisition Ii Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 2040475.
Total stock buying since 2025: $0.
Total stock sales since 2025: $0.
Total stock option exercises since 2025: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,400,000 | $0 | 15,933,334 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 1,400,000 | $0 | 15,933,334 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-26 | Drugs Made In America Acquisition Ii Llc | Buy | 700,000 | .00 | 0 |
| 2025-09-26 | Drugs Made In America Acquisition Ii Llc | Sale | 7,966,667 | .00 | 0 |
| 2025-09-26 | Stockwell Lynn (CEO and Exe. Chair of Board) | Buy | 700,000 | .00 | 0 |
| 2025-09-26 | Stockwell Lynn (CEO and Exe. Chair of Board) | Sale | 7,966,667 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of DMII listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Drugs Made In America Acquisition Ii Corp. (symbol DMII, CIK number 2040475) see the Securities and Exchange Commission (SEC) website.